Therapeutic Effects of Intermittent Fasting Combined with SLBZS and Prebiotics on STZ-HFD-Induced Type 2 Diabetic Mice
Xiaoyu Liu,Pengyun Du,Jianing Xu,Wei Wang,Chenggang Zhang
DOI: https://doi.org/10.2147/dmso.s474196
2024-10-29
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Xiaoyu Liu, Pengyun Du, Jianing Xu, Wei Wang, Chenggang Zhang School of Life Sciences, Beijing University of Chinese Medicine, Beijing, People's Republic of China Correspondence: Chenggang Zhang, School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 102488, People's Republic of China, Email Purpose: This study aims to assess the therapeutic potential of combining Shen-Ling-Bai-Zhu-San (SLBZS) or prebiotics with intermittent fasting (IF) in type 2 diabetes mellitus (T2DM) mice and to investigate the synergistic effects and underlying mechanisms. Methods: Type 2 diabetic mouse models were induced using high-fat diet (HFD) and streptozotocin (STZ), followed by IF treatment. Mice were then grouped for combined therapy with different doses of SLBZS and prebiotics. Fasting blood glucose (FBG) levels, body weight variations, and oral glucose tolerance tests were assessed to elucidate metabolic alterations. The hepatic and renal parameters were evaluated to determine systemic changes in T2DM mice, while the insulin levels were quantified by ELISA to assess glucose homeostasis. Gut microbiota alterations were examined via 16S rRNA sequencing. Alterations of the genes in relevant signaling pathways were analyzed using RT-qPCR. Results: IF improved FBG, body weight, insulin levels, and other diabetes indicators. Combined IF with SLBZS or prebiotics yielded similar effects. Furthermore, it ameliorated dyslipidemia and mitigated hepatic and renal parameters in T2DM mice. Pancreatic tissue histopathology showed islet cell restoration post-intervention. IF therapy reduced the abnormally elevated GSK-3β gene expression and increased the abnormally reduced GLUT2 genes. Further analysis indicated that the combination of IF with prebiotics and high doses of SLBZS upregulated the expression of the INSR and IRS1 genes. Gut microbiota analysis revealed restored diversity and structure, with notable changes in specific bacterial families. At the family level, the contents of Akkermansiaceae and Bifidobacteriaceae were restored. Phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt2) analysis suggested metabolic pathway alterations. Conclusion: IF improved type 2 diabetic symptoms, with combined SLBZS and prebiotics showing similar effects. IF with high concentration of SLBZS and prebiotics doses upregulated the INSR and IRS1 genes and had superior effects on gut microbiota compared to IF alone. Keywords: [type 2 diabetes mellitus, intermittent fasting, prebiotics, Shen-Ling-Bai-Zhu-San] Diabetes, a metabolic disorder characterized primarily by hyperglycemia, is widely prevalent worldwide. According to the 10th edition of the IDF Diabetes Atlas, approximately 537 million adults (aged 20–79 years) globally were living with diabetes in 2021, 1 and this number is predicted to rise to 643 million by 2030 and 783 million by 2045. Of these cases, over 90% are diagnosed as type 2 diabetes, 2 which is influenced by various factors including genetics, lifestyle, and environmental factors. Due to factors such as increasing obesity rates, sedentary lifestyles, and poor dietary habits, the incidence of type 2 diabetes is rising among children, adolescents, and young adults. 3,4 The main causes of type 2 diabetes include insulin resistance and pancreatic β-cell dysfunction. Insulin resistance leads to decreased sensitivity of pancreatic cells, diminished glucose uptake, and impaired glycogen synthesis, resulting in hyperglycemia. To counteract high blood glucose levels, the body increases insulin secretion, but prolonged hyperglycemia damages pancreatic β-cell function, making reversal difficult. Thus, the development of type 2 diabetes is closely associated with insulin resistance and pancreatic β-cell dysfunction. 5 If blood glucose levels are not effectively controlled, diabetes can also lead to damage to the liver and kidneys in the organism. 6,7 Intermittent fasting (IF) is a relatively popular dietary approach in recent years, involving cyclic periods of zero or reduced calorie intake alternated with normal calorie consumption, aimed at preventing and treating metabolic diseases. 8 The three common IF patterns include alternate day fasting (ADF), the 5:2 diet, and time-restricted eating (TRE). 9–11 Clinical trial results have demonstrated that IF can effectively reduce body weight in obese individuals, improve insulin resistance and lipid metabolism, and decrease the incidence of diabetes and cardiovascular diseases. 12 By extending fasting periods, IF maximizes the oxidation of fatty acids and ketones, rather than relying on glucose as the primar -Abstract Truncated-
endocrinology & metabolism